It’s the shorts manipulative way. On good news they short it down enough to discourage new buyers or try and persuade potential investors not to buy and that the news is either not good or it’s bad. This actually works sometimes do you the fact that there is very little media coverage given to CYDY. We
Need to be on fox business news or any on the stock market channels with a company spokesman taking about how leronlimab could soon be entering an untapped 30 billion or 100 billion worldwide market for covid longhaulers.